ARVN.NASDAQArvinas, INC

Form 4: Arvinas Inc. Executive David K. Loomis Reports Stock and Option Awards

Sentiment:

SEC Form 4 Filing


David K. Loomis, Chief Accounting Officer of Arvinas Inc., reports the acquisition of restricted stock units and stock options.

Summary

  • On May 9, 2025, David K. Loomis, Chief Accounting Officer of Arvinas Inc., was granted 11,825 restricted stock units (RSUs) and 18,100 stock options.
  • The RSUs and options were granted pursuant to the company's 2018 Stock Incentive Plan.
  • The RSUs represent a contingent right to receive one share of Arvinas' common stock upon settlement for no consideration.
  • Both the RSUs and options vest over two years, with 1/2 vesting on May 9, 2026, and the remainder on May 9, 2027, subject to continued service with the Issuer.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing regarding executive compensation, so the sentiment is neutral.

Positives

  • The grant of RSUs and stock options aligns the executive's interests with those of the shareholders.
  • The vesting schedule incentivizes continued service with the company.

Future Outlook

The document does not contain any specific forward-looking statements beyond the vesting schedule of the granted securities.

Industry Context

This type of filing is standard for publicly traded companies and reflects compensation practices for executives.

Comparison to Industry Standards

  • Stock option and RSU grants are a common form of executive compensation in the biotechnology industry.
  • Vesting schedules of two years are fairly standard to incentivize long-term commitment.
  • Comparing the size of the grant to similar roles at comparable companies (e.g., Relay Therapeutics, Monte Rosa Therapeutics) would provide further context on the competitiveness of the compensation package.

Stakeholder Impact

  • The grant of equity to executives can align their interests with those of shareholders, potentially leading to increased company value.
  • Employees may view the grant as a positive sign of the company's commitment to its leadership.

Key Dates

DateDescription
05/09/2025Date of transaction: Grant of RSUs and stock options.
05/09/2026First vesting date: 1/2 of RSUs and stock options vest.
05/09/2027Second vesting date: Remaining 1/2 of RSUs and stock options vest.
05/08/2035Expiration date of the stock options.
05/13/2025Date of Form 4 filing.

Keywords

Arvinas, David K. Loomis, Stock Options, Restricted Stock Units, RSUs, ARVN, Form 4, Beneficial Ownership, Insider Trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.